TERT promoter mutations in melanoma survival

Despite advances in targeted therapies, the treatment of advanced melanoma remains an exercise in disease management, hence a need for biomarkers for identification of at risk primary melanoma patients. In this study we aimed to assess the prognostic value of TERT promoter mutations in primary melan...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Cancer
Asıl Yazarlar: Nagore, Eduardo, Heidenreich, Barbara, Rachakonda, Sívaramakrishna, Garcia-Casado, Zaida, Requena, Celia, Soriano, Virtudes, Frank, Christoph, Traves, Victor, Quecedo, Esther, Sanjuan-Gimenez, Josefa, Hemminki, Kari, Teresa Landi, Maria, Kumar, Rajiv
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8238633/
https://ncbi.nlm.nih.gov/pubmed/26875008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.30042
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller